These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

217 related articles for article (PubMed ID: 24914510)

  • 41. Upper gastrointestinal bleeding in critically ill patients: proton-pump inhibitors, histamine-2 receptor antagonists or placebo? Many questions remain unanswered.
    García-Rayado G; Lanas A
    Curr Med Res Opin; 2018 Nov; 34(11):1881-1883. PubMed ID: 30095019
    [No Abstract]   [Full Text] [Related]  

  • 42. Japan aims toward appropriate concomitant use of antiplatelets and antisecretory agents?
    Fujishiro M
    Intern Med; 2009; 48(21):1845-6. PubMed ID: 19881231
    [No Abstract]   [Full Text] [Related]  

  • 43. Comparison of adjuvant therapies by an H2-receptor antagonist and a proton pump inhibitor after endoscopic treatment in hemostatic management of bleeding gastroduodenal ulcers.
    Sakurada T; Kawashima J; Ariyama S; Kani K; Takabayashi H; Ohno S; Kato S; Yakabi K
    Dig Endosc; 2012 Mar; 24(2):93-9. PubMed ID: 22348833
    [TBL] [Abstract][Full Text] [Related]  

  • 44. The short-term medical management of non-variceal upper gastrointestinal bleeding.
    Kovacs TO; Jensen DM
    Drugs; 2008; 68(15):2105-11. PubMed ID: 18840002
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Prophylactic use of gastro-protective agents in patients on low-dose aspirin.
    Balakrishnan S; Jhaj R
    Br J Clin Pharmacol; 2008 Apr; 65(4):621-2. PubMed ID: 18294325
    [No Abstract]   [Full Text] [Related]  

  • 46. Proton Pump Inhibitors vs Histamine-2 Receptor Blockers for Stress Ulcer Prophylaxis in Critically Ill Patients: Issues of Interpretability in Pragmatic Trials.
    Rice TW; Kripalani S; Lindsell CJ
    JAMA; 2020 Feb; 323(7):611-613. PubMed ID: 31950973
    [No Abstract]   [Full Text] [Related]  

  • 47. High-dose pre-endoscopic intravenous proton pump inhibitors in upper gastrointestinal bleeding: Utility or futility?
    Primignani M; Tosetti G
    Dig Liver Dis; 2021 Mar; 53(3):387-388. PubMed ID: 33414085
    [No Abstract]   [Full Text] [Related]  

  • 48. Reply to: High-dose pre-endoscopic intravenous proton pump inhibitors in upper gastrointestinal bleeding: utility or futility?
    Marmo R; Soncini M; Bucci C; Zullo A
    Dig Liver Dis; 2021 Mar; 53(3):389. PubMed ID: 33472768
    [No Abstract]   [Full Text] [Related]  

  • 49. Prevention of gastrointestinal bleeding in critically ill patients.
    Al-Dorzi HM; Arabi YM
    Curr Opin Crit Care; 2021 Apr; 27(2):177-182. PubMed ID: 33395085
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Similar Efficacy of Proton-Pump Inhibitors vs H2-Receptor Antagonists in Reducing Risk of Upper Gastrointestinal Bleeding or Ulcers in High-Risk Users of Low-Dose Aspirin.
    Chan FK; Kyaw M; Tanigawa T; Higuchi K; Fujimoto K; Cheong PK; Lee V; Kinoshita Y; Naito Y; Watanabe T; Ching JY; Lam K; Lo A; Chan H; Lui R; Tang RS; Sakata Y; Tse YK; Takeuchi T; Handa O; Nebiki H; Wu JC; Abe T; Mishiro T; Ng SC; Arakawa T
    Gastroenterology; 2017 Jan; 152(1):105-110.e1. PubMed ID: 27641510
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Drugs for pH control in upper gastrointestinal bleeding.
    Brunner G; Luna P; Thiesemann C
    Aliment Pharmacol Ther; 1995; 9 Suppl 1():47-50. PubMed ID: 7495943
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Prevention of recurrent gastrointestinal bleeding from peptic ulcers.
    Prescrire Int; 2011 Oct; 20(120):246. PubMed ID: 21970096
    [No Abstract]   [Full Text] [Related]  

  • 53. Pneumonia prevention in intubated patients given sucralfate versus proton-pump inhibitors and/or histamine II receptor blockers.
    Grindlinger GA; Cairo SB; Duperre CB
    J Surg Res; 2016 Dec; 206(2):398-404. PubMed ID: 27884335
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Q: do all hospitalized patients need stress ulcer prophylaxis?
    Eisa N; Bazerbachi F; Alraiyes AH; Alraies MC
    Cleve Clin J Med; 2014 Jan; 81(1):23-5. PubMed ID: 24391103
    [No Abstract]   [Full Text] [Related]  

  • 55. Proton pump inhibitors and histamine-2 receptor antagonists in the intensive care setting: focus on therapeutic and adverse events.
    MacLaren R; Kassel LE; Kiser TH; Fish DN
    Expert Opin Drug Saf; 2015 Feb; 14(2):269-80. PubMed ID: 25423448
    [TBL] [Abstract][Full Text] [Related]  

  • 56. [Proton pump inhibitor H2 receptor antagonist].
    Shiotani A; Kamada T; Kusunoki H; Manabe N; Haruma K
    Nihon Rinsho; 2011 Jun; 69(6):1032-8. PubMed ID: 21688623
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Efficacy of H2 receptor antagonists for prevention of upper gastrointestinal bleeding during dual-antiplatelet therapy.
    Yasu T; Sato N; Kurokawa Y; Saito S; Shoji M
    Int J Clin Pharmacol Ther; 2013 Nov; 51(11):854-60. PubMed ID: 24040853
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Effects of gastric medicines on gastroduodenal injury in patients with stable angina during antiplatelet therapy.
    Hokimoto S; Matsui K; Oshima S; Noda K; Kaikita K; Sumida H; Sugiyama S; Ogawa H
    J Cardiol; 2009 Aug; 54(1):71-5. PubMed ID: 19632523
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Off-label use of gastrointestinal medications in the intensive care unit.
    Barletta JF; Lat I; Micek ST; Cohen H; Olsen KM; Haas CE;
    J Intensive Care Med; 2015 May; 30(4):217-25. PubMed ID: 24362446
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Cost-Effectiveness of Histamine
    Hammond DA; Kathe N; Shah A; Martin BC
    Pharmacotherapy; 2017 Jan; 37(1):43-53. PubMed ID: 27809338
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.